We are live on ! Find out more
TCM

Traynor Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 62.36%
This Fund
S&P 500
This Quarter Est. Return
+17.28%
1 Year Est. Return
+62.36%
3 Year Est. Return
+225.14%
5 Year Est. Return
+309.6%
10 Year Est. Return
+1,325.9%
AUM
$299M
AUM Growth
+$58.7M
Cap. Flow
+$29.1M
Cap. Flow %
9.74%
Top 10 Hldgs %
49.2%
Holding
187
New
30
Increased
86
Reduced
50
Closed
12

Top Buys

Rank Stock Value
1
UWM icon
ProShares Ultra Russell2000
UWM
+$5.3M
2
SLY
SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML)
SLY
+$3.54M
3
MUB icon
iShares National Muni Bond ETF
MUB
+$1.37M
4
BIIB icon
Biogen
BIIB
+$1.29M
5
STZ icon
Constellation Brands
STZ
+$1.14M

Top Sells

Rank Stock Value
1
LABD icon
Direxion Daily S&P Biotech Bear 3X ETF
LABD
+$1.29M
2
CELG
Celgene Corp
CELG
+$778K
3
ECL icon
Ecolab
ECL
+$571K
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$368K
5
GILD icon
Gilead Sciences
GILD
+$291K

Sector Composition

Rank Sector Weight
1 Communication Services 13.46%
2 Technology 13.39%
3 Consumer Discretionary 11.28%
4 Healthcare 9.4%
5 Industrials 5.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PHK
126
PIMCO High Income Fund
PHK
$880M
$280K 0.09%
31,064
+7,959
+34% +$69.2K
SCHW
127
Charles Schwab
SCHW
$187B
$263K 0.09%
6,159
-273
-4% -$12.3K
BIV icon
128
Vanguard Intermediate-Term Bond ETF
BIV
$28.9B
$261K 0.09%
3,120
+104
+3% +$8.56K
EW icon
129
Edwards Lifesciences
EW
$51.7B
$258K 0.09%
4,050
-180
-4% -$10.3K
ILMN icon
130
Illumina
ILMN
$28.4B
$250K 0.08%
+828
New +$241K
EEM icon
131
iShares MSCI Emerging Markets ETF
EEM
$29.5B
$245K 0.08%
5,723
-1,704
-23% -$71.7K
CME icon
132
CME Group
CME
$94.8B
$240K 0.08%
1,461
-197
-12% -$34.8K
IBM icon
133
IBM
IBM
$224B
$239K 0.08%
+1,773
New +$226K
NKTR icon
134
Nektar Therapeutics
NKTR
$2.58B
$236K 0.08%
+468
New +$277K
CAT icon
135
Caterpillar
CAT
$387B
$234K 0.08%
1,734
-73
-4% -$9.7K
UBOT icon
136
Direxion Daily Robotics Artificial Intelligence & Automation Index Bull 2X ETF
UBOT
$27M
$234K 0.08%
+10,162
New +$201K
NVS icon
137
Novartis
NVS
$297B
$231K 0.08%
+2,684
New +$215K
CEO
138
DELISTED
CNOOC Limited
CEO
$231K 0.08%
+1,246
New +$211K
VNQ icon
139
Vanguard Real Estate ETF
VNQ
$39B
$226K 0.08%
+2,600
New +$215K
CHY
140
Calamos Convertible and High Income Fund
CHY
$1.06B
$224K 0.08%
20,723
+6,581
+47% +$70.8K
CSL icon
141
Carlisle Companies
CSL
$15.4B
$223K 0.07%
+1,819
New +$210K
SIRI icon
142
SiriusXM
SIRI
$10.1B
$223K 0.07%
3,950
-10
-0.3% -$596
HYS icon
143
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.75B
$222K 0.07%
2,221
-56
-2% -$5.53K
DES icon
144
WisdomTree US SmallCap Dividend Fund
DES
$2.22B
$215K 0.07%
+7,807
New +$213K
GE icon
145
GE Aerospace
GE
$384B
$213K 0.07%
4,280
-165
-4% -$7.77K
DAL icon
146
Delta Air Lines
DAL
$60.1B
$212K 0.07%
4,109
-896
-18% -$44.4K
SU icon
147
Suncor Energy
SU
$70.3B
$211K 0.07%
6,535
-823
-11% -$26.8K
IAGG icon
148
iShares Core International Aggregate Bond Fund
IAGG
$11B
$210K 0.07%
+3,940
New +$207K
ABT icon
149
Abbott
ABT
$187B
$205K 0.07%
+2,567
New +$191K
CPT icon
150
Camden Property Trust
CPT
$11.3B
$203K 0.07%
+2,000
New +$192K
4 5
6
7 8

Similar funds

SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
CAG
Csenge Advisory Group Clearwater, Florida $2.18B AUM 16.73% 1-Year Est. Return
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Traynor Capital Management's Q1 2019 Portfolio in Review

As of Q1 2019, Traynor Capital Management held 187 positions worth $299M, up 24% from $240M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Traynor Capital Management deployed $29.1M of net new capital in Q1 2019, opening 30 new positions and adding to 86 existing holdings. Its largest new stake was ProShares Ultra Russell2000: 162,532 shares worth $1K.

By sector, the portfolio is most concentrated in Communication Services at 13% of assets, down from 14% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Celgene Corp, an estimated $778K trimmed.

  • Traynor Capital Management's largest Q1 2019 buy was ProShares Ultra Russell2000: 162,532 shares worth $1K.
  • Traynor Capital Management added most to Biogen in Q1 2019, an estimated $1.29M increase.
  • Traynor Capital Management's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $778K.
  • Traynor Capital Management fully exited Direxion Daily S&P Biotech Bear 3X ETF in Q1 2019, selling an estimated $1.29M.
  • Traynor Capital Management's ten largest holdings make up 49% of its $299M portfolio in Q1 2019.
  • Traynor Capital Management opened 30 new positions and closed 12 in Q1 2019.
  • Traynor Capital Management's portfolio value rose 24% quarter-over-quarter to $299M.

Based on Traynor Capital Management's 13F filing for Q1 2019, filed 12 Apr 2019.